methyl-beta-cyclodextrin (CBT-008)
/ Cloudbreak Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 27, 2023
Safety, Efficacy and Pharmacokinetics of CBT-008 in Patients With Meibomian Gland Dysfunction
(clinicaltrials.gov)
- P2 | N=92 | Completed | Sponsor: Cloudbreak Therapeutics, LLC | Recruiting ➔ Completed | Trial completion date: Sep 2022 ➔ Jan 2023
Trial completion • Trial completion date
April 29, 2022
Safety, Efficacy and Pharmacokinetics of CBT-008 in Patients With Meibomian Gland Dysfunction
(clinicaltrials.gov)
- P2 | N=90 | Recruiting | Sponsor: Cloudbreak Therapeutics, LLC | Not yet recruiting ➔ Recruiting
Enrollment open
1 to 2
Of
2
Go to page
1